Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BAE Systems heads into its November earnings with a sharp week of losses but a lending market that shows no meaningful short-selling pressure building against it.
The stock fell 6.7% over the past week to close at 1,826p, extending a 6.7% drawdown over the past month. The move is not company-specific. Across the European defence complex, the selling was broad: Thales dropped 3.6% on the week, Leonardo fell 6.1%, Chemring shed 8.3%, and lost almost 10%. held up better at minus 4.2%. The week looks like a sector rotation or risk-off trade rather than anything specific to BAE.
The lending market confirms that read. Borrow availability is extremely loose, far beyond what a crowded short position would look like. With availability running deep into the thousands of percent relative to short interest, shorts are not building. Cost to borrow is 0.57%, essentially the risk-free rate for a stock loan, and has been in a narrow 0.52% to 0.77% band for two months. The short score of 28.4 sits in a low-risk zone and has drifted gently lower over the past two weeks, from 29.2 on September 24 to 28.4 today. Short sellers are not the story here.
The Street remains constructive. The analyst consensus price target is 2,322p against a current price of 1,826p, a gap of roughly 27%. The forward earnings yield is near 5.1%, and the PE of 19.6x has compressed by about 1.5 turns over the past month as the price fell. EV/EBITDA has also pulled back to 11.9x. Factor scores paint a mixed picture: the dividend score ranks in the 97th percentile, and the 12-month forward EPS growth score ranks 82nd, both strong. EPS surprise, however, ranks only 18th, suggesting the company has a history of modest beats or misses rather than consistent outperformance. The ORTEX short score rank of 83 reflects the near-total absence of short-selling pressure.
Institutional ownership is concentrated and largely stable. Capital Research holds 11.5% and added roughly 8.2 million shares as of end-September. BlackRock holds 9.5% and added around 5 million shares over the same period. FMR added 9.5 million shares to a 4.2% stake. The three moves together represent genuine net buying at levels that are above this week's close, and they were reported as of September 30, well before the current dip.
Earnings are due November 6. The last two prints produced meaningful positive reactions: a 3.7% one-day gain after the July 2026 half-year results, extending to nearly 9% over five days. The May 2026 update was weaker, with a 4% one-day fall though the stock recovered to end that week marginally positive. With the share price now sitting roughly 27% below the consensus analyst target and institutional buyers adding through September, the November print is less about whether BAE's order book is growing and more about whether management's guidance holds up against a defence-spending backdrop that has turned more uncertain across European capitals in recent weeks.
See the live data behind this article on ORTEX.
Open BA. on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
